In recent trading session, Evaxion Biotech A/S ADR (NASDAQ:EVAX) saw 0.49 million shares changing hands at last check today with its beta currently measuring -0.26. Company’s recent per share price level of $2.97 trading at $0.14 or 4.95% at last check today assigns it a market valuation of $16.07M. That most recent trading price of EVAX’s stock is at a discount of -358.25% from its 52-week high price of $13.61 and is indicating a premium of 23.91% from its 52-week low price of $2.26. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 81380.0 shares which gives us an average trading volume of 35.92K if we extend that period to 3-months.
For Evaxion Biotech A/S ADR (EVAX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.31 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Evaxion Biotech A/S ADR (NASDAQ:EVAX) trade information
Upright in the green today for gaining 4.95%, in the last five days EVAX remained trading in the red while hitting it’s week-highest on Friday, 09/20/24 when the stock touched $2.97 price level, adding 10.27% to its value on the day. Evaxion Biotech A/S ADR’s shares saw a change of -56.69% in year-to-date performance and have moved -5.71% in past 5-day. Evaxion Biotech A/S ADR (NASDAQ:EVAX) showed a performance of -6.90% in past 30-days. Number of shares sold short was 22048.0 shares which calculate 0.72 days to cover the short interests.
Evaxion Biotech A/S ADR (EVAX) estimates and forecasts
Statistics highlight that Evaxion Biotech A/S ADR is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -1.00% of value to its shares in past 6 months, showing an annual growth rate of 70.37% while that of industry is 17.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 120k for the same. And 3 analysts are in estimates of company making revenue of 120k in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -18.88% during past 5 years.
